In this study of critically ill COVID-19 patients, plasma endostatin levels of 100–200 ng/mL at ICU admission were associated with AKI development on ICU day 1, RRT need, and 90-day mortality independent of age, sex, CRP, and creatinine. This evidence concerns the gene CRP and acute kidney injury.